SCYNEXIS, Inc. Appoints Carole Sable, MD, As Chief Medical Officer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Drug discovery company SCYNEXIS, Inc., today announced that it has appointed infectious disease expert Carole Sable, MD, as Chief Medical Officer. Dr. Sable was most recently a Vice President at Merck & Co., Inc, initially as franchise integrator in Infectious Diseases and more recently as VP, Project Leadership and Management in Neurosciences and Ophthalmology.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC